Covid19,Virus identified. COVID19 , Virus identified
Conditions
Interventions
Intervention 1: Intervention group: For 14 days ,patients received the Spirulina capsule(1g) prepared in Tabriz school of Pharmacy , while visiting the Imam Reza hospital from a researcher , consuming
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: confirmation of Covid19 by PCR test satisfaction to participate in the study
Exclusion criteria
Exclusion criteria: Having an underlying disease peregnancy stop taking the drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin-6 blood levels of patients before and after taking the drug. Timepoint: Before starting the drug and 14 days after taking the drug. Method of measurement: Blood sample analysisfor IL-6 by ELIZA in the labratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum TNF-a levels in patients plasma. Timepoint: Before starting the drug and 14 days after starting the drug. Method of measurement: Blood sample analysis for TNF-a by ELIZA in the laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAkbar Sharifi
Tabriz University of Medical Sciences
Outcome results
None listed